🇰🇷 South Korea Country × Condition
hypertension Clinical Trials in South Korea
Active clinical trials for hypertension with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT06322056
Recruiting
Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease
Enrollment
642 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT06643130 Phase 3
Recruiting
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Enrollment
162 pts
Country
🇰🇷 South Korea
JW Pharmaceutical
View Trial → Frequently Asked Questions
How many hypertension clinical trials are active in South Korea?
There are currently 2 active clinical trials for hypertension with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a hypertension clinical trial in South Korea?
To join a hypertension clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hypertension trials in South Korea?
Active hypertension trials in South Korea span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.